• AstraZeneca Ireland Limited, Dublin, Zweigniederlassung Baar

    ZG
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-170.9.002.368-5
    Sector: Research and development

    Age of the company

    1 Year

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    Capital unknown

    Employees

    PremiumPremium

    Active brands

    0

    Reports for AstraZeneca Ireland Limited, Dublin, Zweigniederlassung Baar

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About AstraZeneca Ireland Limited, Dublin, Zweigniederlassung Baar

    • AstraZeneca Ireland Limited, Dublin, Zweigniederlassung Baar has its legal headquarters in Baar and is active. It operates in the sector «Research and development».
    • The company was founded on 12.04.2024 and has 2 persons in its management.
    • Under «Notifications» you will find all commercial register changes, the most recent one was made on 21.08.2024.
    • The company is registered in the commercial register ZG under the UID CHE-456.386.216.
    • There are 3 other active companies registered at the same address. These include: Alexion Pharma GmbH, AstraZeneca AG, Evinova AG.

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language)

    Unterstützung der Hauptniederlassung bei der Entwicklung von Medikamenten in den drei Haupttherapiebereichen Onkologie, Biopharmazeutika und seltene Krankheiten.

    Customise the company purpose with just a few clicks.

    Other company names

    Source: SOGC

    Past and translated company names

    • AstraZeneca Ireland Limited, Dublin, Baar Branch
    Would you like to update the company name? Click here.

    Other branches (0)

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: AstraZeneca Ireland Limited, Dublin, Zweigniederlassung Baar

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 240821/2024 - 21.08.2024
    Categories: Change in management

    Publication number: HR02-1006110866, Commercial Registry Office Zug, (170)

    AstraZeneca Ireland Limited, Dublin, Zweigniederlassung Baar, in Baar, CHE-456.386.216, ausländische Zweigniederlassung (SHAB Nr. 74 vom 17.04.2024, Publ. 1006011061).

    Hauptsitz in:
    Dublin (IE).

    Eingetragene Personen neu oder mutierend:
    Downey, Alan Dale, irischer Staatsangehöriger, in Leixlip (IE), Leiter der Zweigniederlassung, mit Einzelunterschrift.

    SOGC 240417/2024 - 17.04.2024
    Categories: Company foundation

    Publication number: HR01-1006011061, Commercial Registry Office Zug, (170)

    AstraZeneca Ireland Limited, Dublin, Zweigniederlassung Baar (AstraZeneca Ireland Limited, Dublin, Baar Branch), in Baar, CHE-456.386.216, c/o AstraZeneca AG, Neuhofstrasse 34, 6340 Baar, ausländische Zweigniederlassung (Neueintragung).

    Identifikationsnummer Hauptsitz:
    734129.

    Firma Hauptsitz:
    AstraZeneca Ireland Limited.

    Rechtsform Hauptsitz:
    Limited.

    Hauptsitz:
    Dublin (IE).

    Kapital Hauptsitz:
    USD 300'000.00;
    Liberierung: USD 300'000.00.

    Angaben zur Zweigniederlassung:
    Zweck der Zweigniederlassung: Unterstützung der Hauptniederlassung bei der Entwicklung von Medikamenten in den drei Haupttherapiebereichen Onkologie, Biopharmazeutika und seltene Krankheiten.

    Eingetragene Personen:
    Crisan, Ioana-Victoria, rumänische Staatsangehörige, in Liestal, Leiterin der Zweigniederlassung, mit Einzelunterschrift.

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm